Gralise 15-Day Sample Pack

RxCUI: 2398512
RxNorm name: Gralise 15-Day Sample Pack
Display name: Gralise 15-Day Sample Pack
Full name: Gralise 15-Day Sample Pack
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gralise	GABAPENTIN	Almatica Pharma LLC	466273b1-c9fc-3930-c94b-aa11394d5140	2025-05-01	Warnings, Adverse reactions	Exact identifier rxcui: 2398512

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
466273b1-c9fc-3930-c94b-aa11394d5140	Gralise 15-Day Sample Pack	SY	6	These highlights do not include all the information needed to use GRALISE safely and effectively. See full prescribing information for GRALISE. GRALISE ® (gabapentin) tablets, for oral use Initial U.S. Approval: 1993	20250501
466273b1-c9fc-3930-c94b-aa11394d5140	{9 (Once-Daily gabapentin 300 MG Oral Tablet [Gralise]) / 24 (Once-Daily gabapentin 600 MG Oral Tablet [Gralise]) } Pack [Gralise Sample Pack]	BPCK	6	These highlights do not include all the information needed to use GRALISE safely and effectively. See full prescribing information for GRALISE. GRALISE ® (gabapentin) tablets, for oral use Initial U.S. Approval: 1993	20250501
466273b1-c9fc-3930-c94b-aa11394d5140	Gralise Sample Pack	PSN	6	These highlights do not include all the information needed to use GRALISE safely and effectively. See full prescribing information for GRALISE. GRALISE ® (gabapentin) tablets, for oral use Initial U.S. Approval: 1993	20250501